← FDA Drug Approvals (Drugs@FDA)

IVRA

NDA · New Drug Application · Sponsor: APOTEX · Approved 2023-08-18

Drug application

FDA Application #

NDA217110

Application type

New Drug Application

Brand name

IVRA

Generic name

MELPHALAN HCL

Active ingredients

MELPHALAN HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

APOTEX

Manufacturer

Apotex Corp

First approval

2023-08-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown